عنوان
پدید آورنده
موضوع
رده
QR46.5
QR46
.
5
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
3030046753
(Number (ISBN
3030046761
(Number (ISBN
9783030046750
(Number (ISBN
9783030046767
Erroneous ISBN
3030046745
Erroneous ISBN
9783030046743
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Pharmaceuticals from microbes :
General Material Designation
[Book]
Other Title Information
impact on drug discovery /
First Statement of Responsibility
editors, Divya Arora, Chetan Sharma, Sundeep Jaglan and Eric Lichtfouse.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cham, Switzerland :
Name of Publisher, Distributor, etc.
Springer,
Date of Publication, Distribution, etc.
[2019]
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource
SERIES
Series Title
Environmental chemistry for a sustainable world,
Volume Designation
volume 28
ISSN of Series
2213-7122 ;
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Intro; Preface; Contents; Contributors; Chapter 1: Pharmacological Potential of Marine Microbes; 1.1 Introduction; 1.2 Marine Microbes: The Latent Sources of Bioactive Compounds from Marine Macroorganisms; 1.3 Antibacterial Activity; 1.4 Antifungal and Antiviral Activity; 1.5 Anti-inflammatory Activity; 1.6 Anticancer Activity; 1.7 Antituberculosis and Anticholinesterase Activity; 1.8 Antimalarial Activity; 1.9 Antidiabetic Activity; 1.10 Novel Metabolites Produced by Marine Actinomycetes; 1.11 Miscellaneous Pharmacological Activities of Marine Microbes
Text of Note
1.12 Supply Issue of Bioactive Compounds from Marine Resources1.13 Conclusion; References; Chapter 2: Antiparasitics from Microorganisms; 2.1 Introduction; 2.2 Global and National Status of Parasitic Infections; 2.3 Chemotherapeutics Against Parasitic Infections; 2.3.1 Antiparasitic Drugs Developed from Microbial Metabolites; 2.3.2 Discovery of New Drug Candidates from Microbial Resources; 2.3.3 New Drug Targets and Screening Assays/Technologies; 2.4 Conclusion; References; Chapter 3: Bioactive Compounds from Nocardia: Biosynthesis and Production; 3.1 Introduction
Text of Note
3.2 Classification and Taxonomy3.3 Bioactive Compounds from Nocardia spp. and Their Biological Significance; 3.3.1 Nocardicins; 3.3.2 Nocobactin; 3.3.3 Nocardithiocin; 3.3.4 Nargenicin; 3.3.5 Biosynthesis of Other Metabolites from Nocardia spp.; 3.4 Metabolic Engineering for Production of Bioactive Compounds from Nocardia spp.; 3.5 Future Perspective; 3.6 Conclusion; References; Chapter 4: Bioactive Metabolites Isolated from Microorganisms for Healthcare: Types and Delivery Routes; 4.1 Introduction; 4.2 Bioactive Metabolites as Therapeutics
Text of Note
4.2.1 Microbial Metabolites Having Antidiabetic Properties4.2.2 Microbial Metabolites Having Anticancerous Properties; 4.2.3 Microbial Metabolite Having Antibacterial Properties; 4.2.4 Microbial Metabolites Having Antifungal Properties; 4.3 Delivery of Bioactive Compounds; 4.3.1 Oral Delivery of Bioactive Compounds; 4.3.2 Intradermal Delivery of Bioactive Compounds; 4.3.3 Intravenous Delivery of Bioactive Compounds; 4.4 Conclusions; References; Chapter 5: Siderophores: A Novel Approach to Fight Antimicrobial Resistance; 5.1 Introduction; 5.2 Bacterial Resistance and Current Needs
Text of Note
5.3 Siderophore Iron Uptake System5.3.1 Siderophore Biosynthesis; 5.3.2 Classification of Siderophores; 5.3.3 Siderophores in Gram-Positive Versus Gram-Negative Bacteria; 5.3.4 Siderophores as Virulence Determinants; 5.4 Antimicrobial Applications of Siderophores; 5.4.1 Siderophore-Mediated Drug Delivery; 5.4.1.1 Siderophore-Trojan Horse Systems for Medical Diagnostic Imaging; 5.4.2 Inhibition of Siderophore Biosynthesis; 5.4.3 Iron Starvation via Competitive Chelation; 5.5 Conclusion; References; Chapter 6: An Update on Bioactive Natural Products from Endophytic Fungi of Medicinal Plants
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
This book deals with the noteworthy advancement in the production of bioactive metabolites from microbes and their pharmacological significance. It highlights the pharmacological potential of marine microbes and endophytic fungi and their bioactive secondary metabolites. Emphasis is also given on the significance of probiotics and their specialized molecules in human health and disease as well as their role in dietary intervention for reducing the risk of non-alcoholic fatty liver disease. This work also serves as excellent reference material for researchers, students and academicians in the field of natural product chemistry, pharmacology and applied microbiology.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Springer Nature
Stock Number
com.springer.onix.9783030046750
OTHER EDITION IN ANOTHER MEDIUM
Title
Pharmaceuticals from microbes.
International Standard Book Number
9783030046743
TOPICAL NAME USED AS SUBJECT
Drug development.
Pharmaceutical microbiology.
Drug development.
MEDICAL-- Pharmacology.
Pharmaceutical microbiology.
(SUBJECT CATEGORY (Provisional
MED-- 071000
RNP
RNP
DEWEY DECIMAL CLASSIFICATION
Number
615
.
1/9
Edition
23
LIBRARY OF CONGRESS CLASSIFICATION
Class number
QR46
.
5
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Arora, Divya
Jaglan, Sundeep
Lichtfouse, Eric
Sharma, Chetan
ORIGINATING SOURCE
Date of Transaction
20200823080813.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
